Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

New nature publication from Google Research & Google DeepMind: In this study, we advance AMIE, our research medical AI, from one-off diagnostic conversations toward treating & managing disease over time, using clinical guidelines & drug formularies. More:

Google for Health

32,534 subscribers

46,256 views • 1 month ago •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

Our work on AI to improve cyclone prediction is likely to be quite impactful & save lives. We've been partnering w/ National Hurricane Center, Met Office & others for testing. This builds on years of work on improving general weather prediction using AI from Google DeepMind & Google Research.

Our work on AI to improve cyclone prediction is likely to be quite impactful & save lives. We've been partnering w/ National Hurricane Center, Met Office & others for testing. This builds on years of work on improving general weather prediction using AI from Google DeepMind & Google Research.

Jeff Dean

29,295 views • 1 year ago

We're excited to announce #AlphaFold 3 with Google DeepMind in nature: our new AI model for predicting biomolecule structures with unprecedented breadth and accuracy. Expanding beyond proteins to tackle DNA, RNA, small molecules to fuel advances in biology & drug design 🧵

We're excited to announce #AlphaFold 3 with Google DeepMind in nature: our new AI model for predicting biomolecule structures with unprecedented breadth and accuracy. Expanding beyond proteins to tackle DNA, RNA, small molecules to fuel advances in biology & drug design 🧵

Isomorphic Labs

297,334 views • 2 years ago

Holy moly, another big one by Google DeepMind! "Our SIMA 2 research offers a strong path towards applications in robotics and another step towards AGI in the real world" Google DeepMind just unveiled SIMA 2 - an AI agent that doesn’t just follow instructions but thinks and reasons with you. The first version, SIMA 1, learned to perform over 600 basic actions in 3D environments. SIMA 2 takes a leap forward: it understands goals, holds conversations, and learns from experience. This marks a shift from “Do this” to “Let’s figure out how to achieve this together.” A thread with examples and how it works🧵:

Holy moly, another big one by Google DeepMind! "Our SIMA 2 research offers a strong path towards applications in robotics and another step towards AGI in the real world" Google DeepMind just unveiled SIMA 2 - an AI agent that doesn’t just follow instructions but thinks and reasons with you. The first version, SIMA 1, learned to perform over 600 basic actions in 3D environments. SIMA 2 takes a leap forward: it understands goals, holds conversations, and learns from experience. This marks a shift from “Do this” to “Let’s figure out how to achieve this together.” A thread with examples and how it works🧵:

Chubby♨️

43,309 views • 9 months ago

Weekend experiments in the studio! New collections + AI research + display technology experiments and more. This year, we focused on many R&Ds and can’t wait to share them in museums and exhibitions.

Weekend experiments in the studio! New collections + AI research + display technology experiments and more. This year, we focused on many R&Ds and can’t wait to share them in museums and exhibitions.

Refik Anadol

25,492 views • 2 years ago

Try ImageFX, a new image-generation tool powered by our AI technology Imagen 2. ✨ This experiment in Google Labs takes prompting to a new level, offering additional suggestions through dropdown lists - helping generate & modify visuals more easily. →

Try ImageFX, a new image-generation tool powered by our AI technology Imagen 2. ✨ This experiment in Google Labs takes prompting to a new level, offering additional suggestions through dropdown lists - helping generate & modify visuals more easily. →

Google DeepMind

54,600 views • 2 years ago

🤖 New robotics research from Meta AI & CMU Robotics Institute — RoboAgent can acquire a wide diversity of non-trivial skills + generalize them to hundreds of unseen scenarios — all w/ an order of magnitude less data than prior works in this space. More details ➡️

🤖 New robotics research from Meta AI & CMU Robotics Institute — RoboAgent can acquire a wide diversity of non-trivial skills + generalize them to hundreds of unseen scenarios — all w/ an order of magnitude less data than prior works in this space. More details ➡️

AI at Meta

164,758 views • 3 years ago

We welcome the additional £3 million in funding announced by the Chancellor today to support promising early career cancer researchers. This funding from the Medical Research Charities Early Career Researchers Support Fund is a welcome boost at a time when inflation and the cost of living is squeezing research. We look forward to working with the government to put cancer research funding on a long-term sustainable footing and to tackle the more than £1 billion gap in cancer research funding expected over the next decade. #LongerBetterLives #Budget2024 #InTheNews

We welcome the additional £3 million in funding announced by the Chancellor today to support promising early career cancer researchers. This funding from the Medical Research Charities Early Career Researchers Support Fund is a welcome boost at a time when inflation and the cost of living is squeezing research. We look forward to working with the government to put cancer research funding on a long-term sustainable footing and to tackle the more than £1 billion gap in cancer research funding expected over the next decade. #LongerBetterLives #Budget2024 #InTheNews

Cancer Research UK

13,359 views • 2 years ago

👀 A sneak peek into our latest research Automatic #PBR texturing using: Image-To-Material An AI model coming soon📅 Full PBR predictions from any uploaded photogrammetry scan in ~10 seconds🚀 This research will enable accurate PBR textures for generated meshes in the near future 👋Find us at #SIGGRAPH2025 to learn more! Thanks to Wallace Wainhouse for the scan RealityScan 🧵Follow this thread for more results, over the next few days

👀 A sneak peek into our latest research Automatic #PBR texturing using: Image-To-Material An AI model coming soon📅 Full PBR predictions from any uploaded photogrammetry scan in ~10 seconds🚀 This research will enable accurate PBR textures for generated meshes in the near future 👋Find us at #SIGGRAPH2025 to learn more! Thanks to Wallace Wainhouse for the scan RealityScan 🧵Follow this thread for more results, over the next few days

M-XR

20,304 views • 1 year ago

Massive news from AI and biotech: Google DeepMind co-founder Demis Hassabis has just raised $2.1 billion for Isomorphic Labs. For years, Hassabis and his team have been building powerful AI that can predict protein structures, design brand new molecules, and dramatically speed up drug discovery. Now Isomorphic Labs is turning that technology into a full scale effort to tackle what traditional medicine has struggled with for decades. $2.1 billion. One clear mission: use AI to transform how we fight disease and ultimately cure what was once thought incurable. This is one of the biggest bets yet that the future of medicine will be powered by code. Clinical trials, expanded pipelines, and real world impact are coming. Extremely exciting times ahead for humanity.

Linus ✦ Ekenstam

38,525 views • 3 months ago

The Board of REACT19 regrets to inform our community of the sudden cancellation of this week’s meeting of the Advisory Committee on Immunization Practices (ACIP) at the CDC. The meeting was cancelled following a federal court ruling that blocked recent vaccine policy changes and invalidated the current ACIP advisory panel while legal challenges move forward. For many in our community, this meeting represented a long-awaited opportunity. After more than five years of waiting, patients and families had prepared impact statements in hopes that the urgent need for clinical recognition, research, and care for those suffering from serious post-vaccination conditions would finally be discussed. For those living with these conditions, this cancellation is deeply painful. It means more waiting, more uncertainty, and more time without the clinical guidance needed to help physicians recognize, diagnose, and treat patients who have been suffering for years. Our hearts are with every member of this community who had hoped their voice would finally be heard this week. However, even in this difficult moment, important progress continues. On March 18, REACT19 will still be part of a historic step forward at the CDC. A proposal for a new ICD-10 diagnostic code related to post-COVID-19 vaccination conditions will be presented, opening a public comment period and moving the medical system closer to formally recognizing these patients. Diagnostic codes are more than administrative tools. They are a critical foundation for clinical recognition, medical education, research, insurance coverage, and ultimately the development of treatments. Establishing an ICD-10 code would represent an important step toward building the clinical infrastructure needed to care for patients who have too often been left without answers. While the cancellation of the ACIP meeting is a heartbreaking setback for our community, the work to achieve medical recognition and appropriate care continues. If the U.S. Department of Health and Human Services prevails in its appeal, the ACIP process may resume. In the meantime, REACT19 remains committed to ensuring that the voices of patients are heard and that progress toward recognition, research, and care does not stop. To every patient and family who has shared their story and stood with us through years of uncertainty: we see you, we hear you, and we will continue advocating for the care and recognition you deserve. — Board of Directors REACT19

The Board of REACT19 regrets to inform our community of the sudden cancellation of this week’s meeting of the Advisory Committee on Immunization Practices (ACIP) at the CDC. The meeting was cancelled following a federal court ruling that blocked recent vaccine policy changes and invalidated the current ACIP advisory panel while legal challenges move forward. For many in our community, this meeting represented a long-awaited opportunity. After more than five years of waiting, patients and families had prepared impact statements in hopes that the urgent need for clinical recognition, research, and care for those suffering from serious post-vaccination conditions would finally be discussed. For those living with these conditions, this cancellation is deeply painful. It means more waiting, more uncertainty, and more time without the clinical guidance needed to help physicians recognize, diagnose, and treat patients who have been suffering for years. Our hearts are with every member of this community who had hoped their voice would finally be heard this week. However, even in this difficult moment, important progress continues. On March 18, REACT19 will still be part of a historic step forward at the CDC. A proposal for a new ICD-10 diagnostic code related to post-COVID-19 vaccination conditions will be presented, opening a public comment period and moving the medical system closer to formally recognizing these patients. Diagnostic codes are more than administrative tools. They are a critical foundation for clinical recognition, medical education, research, insurance coverage, and ultimately the development of treatments. Establishing an ICD-10 code would represent an important step toward building the clinical infrastructure needed to care for patients who have too often been left without answers. While the cancellation of the ACIP meeting is a heartbreaking setback for our community, the work to achieve medical recognition and appropriate care continues. If the U.S. Department of Health and Human Services prevails in its appeal, the ACIP process may resume. In the meantime, REACT19 remains committed to ensuring that the voices of patients are heard and that progress toward recognition, research, and care does not stop. To every patient and family who has shared their story and stood with us through years of uncertainty: we see you, we hear you, and we will continue advocating for the care and recognition you deserve. — Board of Directors REACT19

React19 - Official

33,312 views • 5 months ago

No one, and I mean NO one wants to spend extra time writing detailed memos for expense reports when traveling or entertaining clients. The good news? You’re one step closer to automating that entire process away. Introducing Ramp's Google Calendar integration, available today for all Ramp customers! 🚢 Our AI matches data from your calendar to suggest memos, add attendees and effortlessly do your expenses for you - so you don’t have to waste time. I've been dogfooding it and love it. Give it a shot and let us know what you think. Memos are just the start —much more to come from this integration in the coming weeks. Can’t thank our team enough for pulling this one off.

No one, and I mean NO one wants to spend extra time writing detailed memos for expense reports when traveling or entertaining clients. The good news? You’re one step closer to automating that entire process away. Introducing Ramp's Google Calendar integration, available today for all Ramp customers! 🚢 Our AI matches data from your calendar to suggest memos, add attendees and effortlessly do your expenses for you - so you don’t have to waste time. I've been dogfooding it and love it. Give it a shot and let us know what you think. Memos are just the start —much more to come from this integration in the coming weeks. Can’t thank our team enough for pulling this one off.

Eric Glyman

64,614 views • 1 year ago

🌟 Explore an amazing project that brings cultural landmarks to life through an AI-powered digital layer! We have supported our friends from SmartRDI, a cutting-edge R&D spin-off from Universitatea POLITEHNICA din București, on their journey to reimagine heritage in a whole new way, based on federated learning, edge computing and beyond 5G networks as a part of the TrialsNet Project project. 💪 As always, our amazing community played a key role in AI training, by solving over 6,000 data labeling tasks that helped this innovative solution! 🎥 Watch the demo & read more about this case study in our newest blog post:

🌟 Explore an amazing project that brings cultural landmarks to life through an AI-powered digital layer! We have supported our friends from SmartRDI, a cutting-edge R&D spin-off from Universitatea POLITEHNICA din București, on their journey to reimagine heritage in a whole new way, based on federated learning, edge computing and beyond 5G networks as a part of the TrialsNet Project project. 💪 As always, our amazing community played a key role in AI training, by solving over 6,000 data labeling tasks that helped this innovative solution! 🎥 Watch the demo & read more about this case study in our newest blog post:

Timeworx

27,451 views • 1 year ago

Today, we're launching the Runway Game Worlds Beta. Over the last few months, we have been working on research and products that are moving us closer toward a future where you will be able to explore any character, story or world in real time. While generating the pixels of these experiences is one aspect of this new frontier, another is the need for novel mechanics and interfaces. From how stories unfold to how your choices affect the worlds you’re simulating. Today’s beta release marks a first step in this direction, learn more below. (1/5)

Today, we're launching the Runway Game Worlds Beta. Over the last few months, we have been working on research and products that are moving us closer toward a future where you will be able to explore any character, story or world in real time. While generating the pixels of these experiences is one aspect of this new frontier, another is the need for novel mechanics and interfaces. From how stories unfold to how your choices affect the worlds you’re simulating. Today’s beta release marks a first step in this direction, learn more below. (1/5)

Runway

118,827 views • 11 months ago

🚨BREAKING: GOOGLE WARNS 6.9M BITCOIN WILL BE VULNERABLE WHEN QUANTUM COMPUTERS BECOME POWERFUL ENOUGH A new Google Quantum AI whitepaper has identified approximately 6.9 million Bitcoin $BTC vulnerable to future quantum at-rest attacks. Around 1.7 million BTC sits in old Pay-to-Public-Key scripts, with public keys permanently exposed on the blockchain. This includes coins widely believed to belong to Bitcoin's pseudonymous creator Satoshi Nakamoto. No quantum computer powerful enough to exploit this exists today. But the paper warns that when one does, these dormant assets require no transaction to be broadcast — a future attacker could simply derive the private key silently from public data. The research team revealed that a superconducting quantum computer could derive a Bitcoin private key in approximately 9 minutes — just inside Bitcoin's average 10-minute block time. Google warns the coins represent a "fixed, multibillion-dollar target" if protocol changes are not made in time. The paper proposes governments consider legal frameworks for "digital salvage," treating dormant quantum-vulnerable coins similarly to unclaimed sunken treasure, to prevent them falling to rogue states or criminal actors first.

🚨BREAKING: GOOGLE WARNS 6.9M BITCOIN WILL BE VULNERABLE WHEN QUANTUM COMPUTERS BECOME POWERFUL ENOUGH A new Google Quantum AI whitepaper has identified approximately 6.9 million Bitcoin $BTC vulnerable to future quantum at-rest attacks. Around 1.7 million BTC sits in old Pay-to-Public-Key scripts, with public keys permanently exposed on the blockchain. This includes coins widely believed to belong to Bitcoin's pseudonymous creator Satoshi Nakamoto. No quantum computer powerful enough to exploit this exists today. But the paper warns that when one does, these dormant assets require no transaction to be broadcast — a future attacker could simply derive the private key silently from public data. The research team revealed that a superconducting quantum computer could derive a Bitcoin private key in approximately 9 minutes — just inside Bitcoin's average 10-minute block time. Google warns the coins represent a "fixed, multibillion-dollar target" if protocol changes are not made in time. The paper proposes governments consider legal frameworks for "digital salvage," treating dormant quantum-vulnerable coins similarly to unclaimed sunken treasure, to prevent them falling to rogue states or criminal actors first.

BSCN

72,791 views • 4 months ago

SoftBank is reportedly in early talks to back a massive $800M funding round for Munich-based Agile Robots, with a contribution of over $ 300M. The move signals a major escalation in Masayoshi Son's "brains and bodies" strategy to dominate physical AI infrastructure. Why this matters for the robotics industry: 🤖 The Flywheel: Agile Robots isn't just hardware. Founded by German Aerospace Center (DLR) alumni, they vertically integrate AI software with humanoids, warehouse automation, and robotic arms. 🧠 Frontier Ecosystems: Agile ONE was recently named a founding member of NVIDIA’s Cosmos Coalition and is deep in a research partnership with Google DeepMind to bring Gemini to the factory floor. 💰 The Capital Race: Global investment in robotics more than tripled in 2025. SoftBank is pairing this hardware play with its recent $1.4B investment in Skild AI and its $5.4B acquisition of ABB Robotics. While both companies have declined to comment on the early-stage talks, the deal highlights a furious shift toward deploying foundational AI in physical manufacturing and logistics.

SoftBank is reportedly in early talks to back a massive $800M funding round for Munich-based Agile Robots, with a contribution of over $ 300M. The move signals a major escalation in Masayoshi Son's "brains and bodies" strategy to dominate physical AI infrastructure. Why this matters for the robotics industry: 🤖 The Flywheel: Agile Robots isn't just hardware. Founded by German Aerospace Center (DLR) alumni, they vertically integrate AI software with humanoids, warehouse automation, and robotic arms. 🧠 Frontier Ecosystems: Agile ONE was recently named a founding member of NVIDIA’s Cosmos Coalition and is deep in a research partnership with Google DeepMind to bring Gemini to the factory floor. 💰 The Capital Race: Global investment in robotics more than tripled in 2025. SoftBank is pairing this hardware play with its recent $1.4B investment in Skild AI and its $5.4B acquisition of ABB Robotics. While both companies have declined to comment on the early-stage talks, the deal highlights a furious shift toward deploying foundational AI in physical manufacturing and logistics.

Humanoids daily

16,714 views • 2 months ago

For years, Kala-Azar was a death sentence for some of India’s poorest families. And treatment itself felt like punishment. 15 injections. Every alternate day. A drug that sometimes caused dangerous heart complications. For many families, surviving the disease wasn’t the only battle, a month away from work often meant losing the income that kept food on the table. Prof. Shyam Sundar from Banaras Hindu University looked at this reality and asked: What if one dose is enough? In 2010, his landmark study in the New England Journal of Medicine showed that a single-dose liposomal amphotericin B treatment could cure Kala-Azar with a 95.6% success rate. One breakthrough changed everything. He also helped introduce rapid diagnostic strip tests that cut detection time from weeks to minutes. WHO updated treatment protocols. The medicine that cost nearly ₹19,000 per vial started reaching India free through donation programmes. Today, India has moved from battling Kala-Azar outbreaks to pushing toward elimination. And behind that story is a professor who spent decades making sure poverty didn’t decide who lives and who dies. #PadmaShri #HealthcareHeroes #MedicalInnovation #PublicHealth #IndiaNews [Padma Shri, Kala Azar, Public Health, Medical Innovation]

For years, Kala-Azar was a death sentence for some of India’s poorest families. And treatment itself felt like punishment. 15 injections. Every alternate day. A drug that sometimes caused dangerous heart complications. For many families, surviving the disease wasn’t the only battle, a month away from work often meant losing the income that kept food on the table. Prof. Shyam Sundar from Banaras Hindu University looked at this reality and asked: What if one dose is enough? In 2010, his landmark study in the New England Journal of Medicine showed that a single-dose liposomal amphotericin B treatment could cure Kala-Azar with a 95.6% success rate. One breakthrough changed everything. He also helped introduce rapid diagnostic strip tests that cut detection time from weeks to minutes. WHO updated treatment protocols. The medicine that cost nearly ₹19,000 per vial started reaching India free through donation programmes. Today, India has moved from battling Kala-Azar outbreaks to pushing toward elimination. And behind that story is a professor who spent decades making sure poverty didn’t decide who lives and who dies. #PadmaShri #HealthcareHeroes #MedicalInnovation #PublicHealth #IndiaNews [Padma Shri, Kala Azar, Public Health, Medical Innovation]

The Better India

269,144 views • 2 months ago

Milestone unlocked 🔓🔑. Today, we announced positive topline results from Emerge, the first Phase 3 study of our pharmaceutical LSD for major depressive disorder (MDD). These results mark a significant step forward in our mission to forge a new era of psychiatry, one with novel treatments that target underlying cause of disease, not just symptoms. For patients who may have run out of options, these results matter. We’re energized by the momentum ahead as we continue pursuing potential new treatment options for the millions of people living with a mental health disorder. Learn more about this significant step:

Milestone unlocked 🔓🔑. Today, we announced positive topline results from Emerge, the first Phase 3 study of our pharmaceutical LSD for major depressive disorder (MDD). These results mark a significant step forward in our mission to forge a new era of psychiatry, one with novel treatments that target underlying cause of disease, not just symptoms. For patients who may have run out of options, these results matter. We’re energized by the momentum ahead as we continue pursuing potential new treatment options for the millions of people living with a mental health disorder. Learn more about this significant step:

Definium Therapeutics

19,313 views • 1 month ago

For more than 15 years, Codrops has been a place for sharing experimental demos that push the boundaries of web design and development. Over time, we've also highlighted many creative demos from the community in our demo roundups and newsletter. For this reason we have evolved our Demos Hub into the new Creative Hub, which brings everything together in one place: a growing collection of hand-picked, open-source demos from Codrops and beyond. It's a space to discover, learn from, and celebrate the creativity of the web community. We're curating this collection carefully, but we also welcome submissions from creators who'd like to share their work. Come and explore the new Creative Hub:

For more than 15 years, Codrops has been a place for sharing experimental demos that push the boundaries of web design and development. Over time, we've also highlighted many creative demos from the community in our demo roundups and newsletter. For this reason we have evolved our Demos Hub into the new Creative Hub, which brings everything together in one place: a growing collection of hand-picked, open-source demos from Codrops and beyond. It's a space to discover, learn from, and celebrate the creativity of the web community. We're curating this collection carefully, but we also welcome submissions from creators who'd like to share their work. Come and explore the new Creative Hub:

Codrops

30,251 views • 11 months ago